Cargando…

Identification of key genes as potential biomarkers for triple-negative breast cancer using integrating genomics analysis

Triple-negative breast cancer (TNBC) accounts for the worst prognosis of all types of breast cancers due to a high risk of recurrence and a lack of targeted therapeutic options. Extensive effort is required to identify novel targets for TNBC. In the present study, a robust rank aggregation (RRA) ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Guansheng, Lou, Weiyang, Shen, Qinyan, Yu, Kun, Zheng, Yajuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947886/ https://www.ncbi.nlm.nih.gov/pubmed/31974598 http://dx.doi.org/10.3892/mmr.2019.10867

Ejemplares similares

Exploring specific prognostic biomarkers in triple-negative breast cancer
por: Bao, Chang, et al.
Publicado: (2019)

Identification of Potential Key Genes Associated With the Pathogenesis, Metastasis, and Prognosis of Triple-Negative Breast Cancer on the Basis of Integrated Bioinformatics Analysis
por: Zhao, Bin, et al.
Publicado: (2020)

Identification of Key Genes and Pathways in Triple-Negative Breast Cancer by Integrated Bioinformatics Analysis
por: Dong, Pengzhi, et al.
Publicado: (2018)

Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancer
por: Lv, Xuemei, et al.
Publicado: (2019)

Identification of Key Genes Affecting the Tumor Microenvironment and Prognosis of Triple-Negative Breast Cancer
por: Yi, Jiarong, et al.
Publicado: (2021)

Integrated bioinformatic analysis of potential biomarkers of poor prognosis in triple-negative breast cancer
por: Bissanum, Rassanee, et al.
Publicado: (2022)

Identification of NUF2 and FAM83D as potential biomarkers in triple-negative breast cancer
por: Zhai, Xiuming, et al.
Publicado: (2020)

Construction of an mRNA-miRNA-lncRNA network prognostic for triple-negative breast cancer
por: Huang, Yuan, et al.
Publicado: (2021)

Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer
por: Zheng, Yajuan, et al.
Publicado: (2020)

Corrigendum: Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer
por: Zheng, Yajuan, et al.
Publicado: (2020)

Identification of CXCR4 and CXCL10 as Potential Predictive Biomarkers in Triple Negative Breast Cancer (TNBC)
por: Chuan, Tian, et al.
Publicado: (2020)

Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer
por: Meyer, Braydon, et al.
Publicado: (2021)

Identification of potential oncogenes in triple-negative breast cancer based on bioinformatics analyses
por: Xiao, Xiao, et al.
Publicado: (2021)

Tumor Microenvironment: Key Players in Triple Negative Breast Cancer Immunomodulation
por: Zheng, Hongmei, et al.
Publicado: (2021)

LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer
por: Lv, Mingming, et al.
Publicado: (2016)

miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells
por: Chen, Danni, et al.
Publicado: (2018)

PIM-1 kinase: a potential biomarker of triple-negative breast cancer
por: Chen, Jieying, et al.
Publicado: (2019)

Integrating Germline and Somatic Mutation Information for the Discovery of Biomarkers in Triple-Negative Breast Cancer
por: Wu, Jiande, et al.
Publicado: (2019)

RP11-480I12.5-004 Promotes Growth and Tumorigenesis of Breast Cancer by Relieving miR-29c-3p-Mediated AKT3 and CDK6 Degradation
por: Lou, Weiyang, et al.
Publicado: (2020)

Identification of tRNA‐derived small noncoding RNAs as potential biomarkers for prediction of recurrence in triple‐negative breast cancer
por: Feng, Wanting, et al.
Publicado: (2018)

Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
por: Jézéquel, Pascal, et al.
Publicado: (2019)

Immune-related biomarkers in triple-negative breast cancer
por: Zhang, Juan, et al.
Publicado: (2021)

A Key mRNA-miRNA-lncRNA Competing Endogenous RNA Triple Sub-network Linked to Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Zhang, Junjie, et al.
Publicado: (2020)

TTK is a favorable prognostic biomarker for triple-negative breast cancer survival
por: Xu, Qianqian, et al.
Publicado: (2016)

Key Players in Choline Metabolic Reprograming in Triple-Negative Breast Cancer
por: Iorio, Egidio, et al.
Publicado: (2016)

Tumor-Associated Macrophages: Key Players in Triple-Negative Breast Cancer
por: Qiu, Xia, et al.
Publicado: (2022)

Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer
por: Tian, Tian, et al.
Publicado: (2021)

PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer
por: Spasojevic, Caroline, et al.
Publicado: (2018)

Potential Management of Circulating Tumor DNA as a Biomarker in Triple-Negative Breast Cancer
por: Shang, Mao, et al.
Publicado: (2018)

A Novel Role for Cathepsin S as a Potential Biomarker in Triple Negative Breast Cancer
por: Wilkinson, Richard D. A., et al.
Publicado: (2019)

Extracellular Vesicles in Triple–Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential
por: Das, Kaushik, et al.
Publicado: (2023)

Identification of the Thioredoxin-Like 2 Autoantibody as a Specific Biomarker for Triple-Negative Breast Cancer
por: Chung, Jee Min, et al.
Publicado: (2018)

Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer
por: Zhang, Hao, et al.
Publicado: (2023)

The Triple-Negative Breast Cancer Database: an omics platform for reference, integration and analysis of triple-negative breast cancer data
por: Raju, Rajesh, et al.
Publicado: (2014)

Identification of Key Prognostic Genes of Triple Negative Breast Cancer by LASSO-Based Machine Learning and Bioinformatics Analysis
por: Chen, De-Lun, et al.
Publicado: (2022)

Identification of potential core genes in triple negative breast cancer using bioinformatics analysis
por: Li, Man-Xiu, et al.
Publicado: (2018)

Identification of Potential Key Biomarkers and Immune Infiltration in Oral Lichen Planus
por: Geng, Lou, et al.
Publicado: (2022)

BCL11A confers cell invasion and migration in androgen receptor-positive triple-negative breast cancer
por: Wang, Xin, et al.
Publicado: (2020)

Therapeutic Effect of Doxorubicin-Chlorin E6-Loaded Mesoporous Silica Nanoparticles Combined with Ultrasound on Triple-Negative Breast Cancer
por: Xu, Peng, et al.
Publicado: (2020)

Truncated HDAC9 identified by integrated genome-wide screen as the key modulator for paclitaxel resistance in triple-negative breast cancer
por: Lian, Bi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5711926grcn56lghrij58890d3